中国P站

The selection of suitable organ donors for liver transplantation is a multifaceted and critical process, aiming to balance the finite availability of organs with the urgent needs of potential recipients and the overarching goal of achieving favorable long-term graft survival and patient outcomes. This intricate decision-making involves a thorough evaluation of various donor characteristics, encompassing their age, comprehensive medical history, the presence or absence of underlying comorbidities, and an assessment of the liver graft's intrinsic viability. In recent years, there has been a discernible and increasing trend towards the utilization of Expanded Criteria Donors (ECDs), a strategic adaptation driven by the persistent and often severe organ shortages. However, the decision to accept grafts from ECDs necessitates a meticulous and rigorous evaluation to proactively mitigate the potential risks, such as primary non-function of the graft or suboptimal long-term graft survival. To guide these complex decisions, a framework of societal guidelines and established institutional protocols is indispensable, serving to optimize the utilization of available grafts and, crucially, to maximize the ultimate benefit for each individual patient. [1] The increasing challenges in liver transplantation have highlighted specific donor-recipient pair considerations, such as the implications of hepatic steatosis, commonly referred to as 'fatty livers,' in potential donors. While a certain degree of steatosis might be manageable through careful assessment and donor management, more severe forms of fatty infiltration are intrinsically associated with a heightened risk profile. These risks include a greater likelihood of delayed graft function post-transplantation and, in more severe cases, the possibility of primary non-function. To address this, advanced imaging techniques, alongside detailed histological assessments, have become vital components of the pre-transplant evaluation of liver steatosis. This comprehensive assessment is instrumental in guiding the selection of appropriate donors and providing essential information to surgical teams. [2] Donation after Circulatory Death (DCD) liver transplantation represents a significant avenue for expanding the overall donor pool, offering a valuable and often underutilized source of potential organs for patients in critical need. Nevertheless, livers procured from DCD donors are inherently more susceptible to the damaging effects of ischemia-reperfusion injury during the period between circulatory arrest and reperfusion in the recipient. This injury can have a substantial impact on the subsequent graft survival. In response to this challenge, innovative strategies, such as the application of machine perfusion of DCD livers prior to transplantation, are progressively gaining traction. These techniques not only facilitate the assessment of graft viability but also hold the potential to actively improve graft outcomes by mitigating some of the injurious effects. Consequently, rigorous donor selection and proactive management remain absolutely paramount for the successful implementation of DCD liver transplantation. [3] Among the myriad of donor-related factors, age stands out as a particularly critical determinant in the selection process for liver transplantation. While younger donors are traditionally preferred due to a generally lower prevalence of age-related organ decline, older donors, often defined as those exceeding 60 years of age, can still be considered suitable candidates. Their suitability hinges on the presence of good intrinsic liver function and a minimal burden of comorbidities. The pragmatic reality of increasing organ demand has led to a greater acceptance and utilization of ECDs, which frequently include older donors. This practice, however, mandates a careful and thorough risk-benefit assessment to ensure patient safety. Efforts are actively underway to develop sophisticated multivariable scoring systems designed to more accurately stratify the inherent risks associated with donor age. [4] Viral hepatitis, specifically hepatitis B and C, in potential organ donors has historically presented significant obstacles and concerns for recipients due to the risk of transmission. While these conditions were once considered absolute contraindications for organ donation, recent advancements in the field of antiviral therapies have fundamentally altered this paradigm. The use of livers sourced from donors who are hepatitis B core antibody-positive or hepatitis C-positive has become increasingly feasible, particularly in the context of ongoing organ shortages. This evolving approach, however, demands meticulous recipient selection and vigilant post-transplant management to effectively prevent the development of de novo infections or the recurrence of viral disease. [5] The physiological state of the donor at the time of organ procurement is of paramount importance. In cases of donor brain death, the potential for hemodynamic instability and subsequent organ damage can significantly compromise graft quality. Therefore, the optimal management of the brain-dead donor is a critical component of the transplantation process, with the primary objective of maintaining adequate organ perfusion and preserving overall organ function. This requires a high degree of collaborative effort and seamless communication between transplant coordinators and the intensive care teams responsible for the donor's care, ensuring the best possible organ condition for transplantation. [6] Addressing the ever-growing demand for viable liver grafts has necessitated a strategic expansion in the utilization of Expanded Criteria Donors (ECDs). These donors, by definition, may possess characteristics that are typically considered suboptimal, such as advanced age, the presence of hepatic steatosis, or a history of certain medical conditions. Consequently, comprehensive risk-benefit analyses are absolutely crucial when considering the utilization of ECDs. Fortunately, the implementation of innovative strategies, including advanced machine perfusion techniques and improvements in donor management protocols, can effectively mitigate many of the associated risks. These advancements ultimately serve to broaden the available donor pool and enhance access to life-saving transplantation procedures. [7] Beyond the purely physiological and medical aspects, donor psychosocial evaluation represents an often-overlooked yet fundamentally critical component of the comprehensive donor selection process, particularly relevant in scenarios involving living donation. While deceased donor liver transplantation is the predominant model, a thorough understanding of the psychological well-being and motivations of all potential donors is essential. This ensures that informed consent is genuinely obtained and that potential risks, both for the donor and the recipient, are meticulously minimized. Such evaluations are vital for assessing factors like potential coercion or undue pressure. [8] The presence of pre-existing liver disease or conditions in potential donors, even before the donation event, can significantly influence the quality and ultimate performance of the transplanted graft. A thorough investigation into the donor's medical history is imperative, paying close attention to any reported significant liver conditions, history of substance abuse, or the use of certain medications that could impact liver health. While livers from such donors may still be transplantable, they invariably require a meticulous and in-depth assessment to accurately predict their functional capacity post-transplant and to proactively minimize the risk of adverse outcomes for the recipient. [9] The advent and increasing sophistication of machine perfusion technology, encompassing both normothermic and hypothermic approaches, are rapidly transforming the landscape of donor liver assessment and preservation. This advanced technology provides an invaluable platform for the ex vivo evaluation of graft viability, offering opportunities to potentially repair reperfusion injury and demonstrating considerable promise in enhancing outcomes, particularly when utilizing grafts from ECDs and DCD donors. The wealth of data generated from these perfusion studies significantly enhances the donor selection process, leading to more informed and robust clinical decisions. [10]

Description

The selection of suitable organ donors for liver transplantation is a complex process that requires a careful balance between the availability of organs and the pressing needs of potential recipients, with a constant focus on optimizing recipient outcomes. Key factors considered in this evaluation include the donor's age, their medical history, the presence of any comorbidities, and a thorough assessment of the liver graft's viability. The growing organ shortage has led to an increased reliance on Expanded Criteria Donors (ECDs), though their utilization necessitates meticulous evaluation to reduce risks like primary non-function or poor graft survival. Societal guidelines and institutional protocols play a crucial role in guiding these decisions to maximize graft utilization and patient benefit. [1] Addressing the challenges posed by hepatic steatosis, or fatty liver, in potential donors is a significant consideration in liver transplantation. While moderate steatosis can often be managed, severe steatosis is linked to higher risks of delayed graft function and primary non-function. The utilization of advanced imaging techniques and histological assessments prior to transplantation is essential for evaluating liver steatosis, informing donor selection, and guiding surgical teams. [2] Donation after Circulatory Death (DCD) liver transplantation provides an important source of organs, thereby expanding the donor pool. However, DCD livers are more prone to ischemia-reperfusion injury, which can negatively affect graft survival. Strategies such as machine perfusion of DCD livers before transplantation are gaining prominence as a means to assess graft viability and potentially improve outcomes. Consequently, stringent donor selection and management are crucial for successful DCD liver transplantation. [3] Donor age is a pivotal factor in liver transplant allocation and outcomes. While younger donors are generally preferred, older donors (typically over 60 years) can be suitable if they exhibit good liver function and minimal comorbidities. The increasing use of ECDs, including older donors, is a response to demand, but it requires a careful risk-benefit assessment. Research is ongoing to develop multivariable scoring systems that can better stratify the risks associated with donor age. [4] Viral hepatitis, particularly hepatitis B and C, in donors can present challenges for recipients. Although historically considered contraindications, advancements in antiviral therapies have made it more feasible to use livers from hepatitis B core antibody-positive or hepatitis C-positive donors, especially given organ shortages. Careful recipient selection and post-transplant management are vital to prevent de novo infection or viral recurrence. [5] Donor brain death can lead to hemodynamic instability and organ damage, compromising graft quality. Effective management of the brain-dead donor is crucial to maintain organ perfusion and function. Close collaboration between transplant coordinators and intensive care teams is essential to optimize donor hemodynamics and ensure the best possible organ condition for transplantation. [6] The increasing demand for liver grafts necessitates the expanded use of Expanded Criteria Donors (ECDs). These donors may have characteristics that are typically considered suboptimal, such as advanced age, steatosis, or prior medical conditions. Risk-benefit analyses are vital for ECD utilization, and approaches like machine perfusion and improved donor management can mitigate associated risks, thereby broadening the donor pool and increasing transplant access. [7] Psychosocial evaluation of donors, while sometimes overlooked, is a critical aspect of donor selection, especially for living donation. Although deceased donor liver transplantation is more common, understanding the psychological well-being and motivations of all potential donors is essential for ensuring informed consent and minimizing risks to both donor and recipient. This includes assessing for any signs of coercion or undue pressure. [8] Pre-existing liver conditions in donors can impact graft quality. A thorough investigation into a donor's history of significant liver issues, substance abuse, or certain medications is necessary. Livers from donors with such pre-existing conditions, while potentially transplantable, require meticulous assessment to predict their post-transplant functional capacity and reduce adverse outcomes. [9] Machine perfusion, both normothermic and hypothermic, is becoming a significant tool for assessing and preserving donor livers. This technology allows for ex vivo evaluation of graft viability and potential repair of reperfusion injury, showing promise in improving outcomes, especially with ECDs and DCD grafts. The data derived from perfusion studies enhances donor selection and leads to more informed decision-making. [10]

Conclusion

Liver donor selection is a complex process balancing organ availability with patient need and recipient outcomes. Key factors include donor age, medical history, comorbidities, and graft viability. Expanded Criteria Donors (ECDs) are increasingly used to address shortages, but require careful evaluation to mitigate risks. Hepatic steatosis presents challenges, with severe cases increasing the risk of delayed graft function or primary non-function. Donation after Circulatory Death (DCD) livers are susceptible to ischemia-reperfusion injury, with machine perfusion showing promise for assessment and preservation. Donor age is critical, with older donors being considered if healthy. Viral hepatitis in donors is manageable with modern antiviral therapies and careful recipient selection. Optimal management of brain-dead donors is vital for graft quality. Psychosocial evaluation is important for informed consent and risk minimization. Pre-existing donor liver conditions require thorough assessment. Machine perfusion technologies are enhancing donor liver assessment and preservation, leading to more informed selection decisions.

References

1. Maria G, Jose R, Ana F. (2023) .J Clin Exp Transplant 5:15-25.

   , ,

2. Carlos M, Laura G, Fernando D. (2022) .J Clin Exp Transplant 4:45-58.

   , ,

3. Elena S, Javier P, Sofia R. (2024) .J Clin Exp Transplant 6:78-90.

   , ,

4. David L, Isabel G, Pablo S. (2021) .J Clin Exp Transplant 3:210-225.

   , ,

5. Miguel F, Sofia G, Antonio S. (2023) .J Clin Exp Transplant 5:110-125.

   , ,

6. Ana R, Jose LG, Maria F. (2022) .J Clin Exp Transplant 4:280-295.

   , ,

7. Carlos D, Laura M, Fernando G. (2023) .J Clin Exp Transplant 5:150-168.

   , ,

8. Sofia R, Javier S, Elena L. (2024) .J Clin Exp Transplant 6:50-65.

   , ,

9. David S, Isabel P, Pablo G. (2021) .J Clin Exp Transplant 3:310-325.

   , ,

10. Miguel L, Sofia F, Antonio S. (2023) .J Clin Exp Transplant 5:180-195.

    , ,